PHILADELPHIA, PA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)LUNG CANCER RESEARCH FOUNDATION, founded in 2005, is a community nonprofit in the Medical Research sector that reported $7.4M in total revenue in fiscal year 2024. Revenue grew 16% year-over-year, indicating healthy expansion. The organization ran a surplus of $1.1M, a strong 15% operating margin.
THE MISSION OF THE LUNG CANCER RESEARCH FOUNDATION IS TO IMPROVE LUNG CANCER OUTCOMES BY FUNDING RESEARCH FOR THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF LUNG CANCER.
RESEARCH: EACH YEAR, LCRF AWARDS RESEARCH GRANTS TO RECIPIENTS AROUND THE WORLD THAT DEMONSTRATE PROMISE AND INGENUITY IN THEIR WORK. INVESTIGATORS ARE SELECTED FROM HUNDREDS OF APPLICANTS AND...
RESEARCH: EACH YEAR, LCRF AWARDS RESEARCH GRANTS TO RECIPIENTS AROUND THE WORLD THAT DEMONSTRATE PROMISE AND INGENUITY IN THEIR WORK. INVESTIGATORS ARE SELECTED FROM HUNDREDS OF APPLICANTS AND REPRESENT SOME OF THE BRIGHTEST MINDS COMMITTED TO IMPROVING OUTCOMES FOR LUNG CANCER PATIENTS. THEY COME FROM VARIOUS CAREER PATHS INCLUDING SCIENTISTS, PHYSICIANS, STUDENTS, AND FELLOWS, AND WORKING ON A VARIETY OF INNOVATIVE RESEARCH PROJECTS RELATED TO LUNG CANCER RESEARCH.SEE SCHEDULE O FOR ADDITIONAL INFORMATION.
PATIENT EDUCATION & OUTREACH: WE PROVIDE UP-TO-DATE AND CREDIBLE SOURCES OF INFORMATION ON DIAGNOSIS, TREATMENT, AND WHAT TO EXPECT FROM TREATMENT THROUGH OUR FREE EDUCATIONAL MATERIALS. WE ALSO HAVE...
PATIENT EDUCATION & OUTREACH: WE PROVIDE UP-TO-DATE AND CREDIBLE SOURCES OF INFORMATION ON DIAGNOSIS, TREATMENT, AND WHAT TO EXPECT FROM TREATMENT THROUGH OUR FREE EDUCATIONAL MATERIALS. WE ALSO HAVE TOOLS TO HELP YOU FACILITATE DISCUSSIONS WITH YOUR HEALTHCARE TEAM SO YOU CAN PLAY AN ACTIVE ROLE IN TREATMENT DECISIONS. OUR MATERIALS ARE AVAILABLE IN BOTH DIGITAL DOWNLOAD AND PRINT FORMAT.SEE SCHEDULE O FOR ADDITIONAL INFORMATION.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $7,405,105 | $6,387,172 | +0.2% |
| Expenses | $6,266,597 | $6,423,446 | 0.0% |
| Net Income | $1,138,508 | $-36,274 | -32.4% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| COLLEEN CONNOR-ZIEGLER | CHAIR | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| BRENDON M STILES MD | VICE CHAIR | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| REINA HONTS | VICE CHAIR | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| AARON M TIGHE | TREASURER | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| BRUCE DUNBAR | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| RAY E CHALME | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MATTHEW CIPRIANI | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| PETER FRY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JILL FURMAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JILL MORNINGSTAR | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SCOTT MORRIS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KATE O'DONNELL | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KATERINA POLITI PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TEJAL PATEL | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOAN H SCHILLER MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MARY ANN TIGHE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ROSE ANN WEINSTEIN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KELLY A BULLOCK | SR. DIRECTOR, FINANCE & ADMIN | 40.00 |
Officer
|
$126,230 | $38,186 | $164,416 |
| AUBREY RHODES | EXECUTIVE DIRECTOR | 40.00 |
Officer
|
$199,958 | $24,335 | $224,293 |
| ANTOINETTE WOZNIAK | CHIEF SCIENTIFIC OFFICER | 40.00 |
Key Emp
|
$224,459 | $34,565 | $259,024 |
| STACEY BOWERS | SR. DIRECTOR, PARTNERSHIPS | 40.00 |
Highest
|
$133,569 | $43,658 | $177,227 |
| DHRUBA DEB | SR. DIRECTOR, RESEARCH & ADMIN | 40.00 |
Highest
|
$122,958 | $14,592 | $137,550 |
| NATALIE REILLY-FINCH | SR. DIRECTOR, PHILANTHROPY | 40.00 |
Highest
|
$137,596 | $4,128 | $141,724 |
| SHEILA SULLIVAN | SR. DIRECTOR, MARKETING & COMMUNICATIONS | 40.00 |
Highest
|
$134,779 | $36,107 | $170,886 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $7,405,105 | $6,266,597 | $7,529,664 | $1,138,508 |
| 2023 | $6,387,172 | $6,423,446 | $6,946,397 | $-36,274 |
| 2022 | $6,603,556 | $6,556,930 | $5,557,342 | $46,626 |
| 2021 | $6,154,252 | $5,340,488 | $5,738,095 | $813,764 |
| 2020 | $5,312,440 | $5,028,019 | $4,581,958 | $284,421 |
| 2019 | $5,337,706 | $5,538,774 | $3,971,966 | $-201,068 |
| 2018 | $5,524,578 | $6,326,711 | $5,021,919 | $-802,133 |
Compare LUNG CANCER RESEARCH FOUNDATION with other nonprofits in Pennsylvania and across the country.